According to foreign media reports, the world's largest pork producer Smithfield Foods has opened an independent bioscience production chain, specifically for the provision of pig organs for medical treatment . The company believes that this will eventually fill the gap in human organ donation and provide a way for patients waiting for organ transplants. The transplanting of pig organs to humans has been a developmental experience for several years, but recently scientists have made a series of breakthroughs that have broken some of the previous technical obstacles that led to failure. “Our main business has been dominated by Bacon, sausage, fresh pork and other foods,†said Courtney Stanton, vice president of biosciences at Smithfield Foods, in an interview. “We want to Medical Equipment and the scientific community know that medical care is also a focus area of ​​our attention." Figure 1: Smithfield Foods believes that this will eventually fill the gap in human organ donation and provide a way for patients waiting for organ transplants. If a patient suffers from organ failure and is incapable of medical treatment, an organ transplant is required. The use of animal organs can effectively solve the problem of insufficient organs. According to the United Nations Joint Organ Sharing Network (UNOS), an average of 22 patients die every day while waiting for an organ transplant. Smithfield Foods has begun collecting organs for medical use from 16 million pigs that are slaughtered each year. The company wants to sell related products directly to researchers and medical companies without having to go through a third party. Stanton pointed out that the market value of pork by-products for medical, pet food and non-food use in the United States exceeds $100 billion, which does not include animal organs transplanted to humans. Smithfield Foods has signed contracts with the two agencies, but Stanton is reluctant to disclose specific information. “There is huge potential in this area. It’s critical for us to be at the forefront of development and focus on building partnerships. ." Pigs have always been an ideal source of transplanted organs because their organs are very close to human organs. For example, the size of a heart when a pig is slaughtered is approximately equal to the size of an adult heart. Other organs that can be used for human transplantation include the kidneys, liver, and lungs. However, previous transplant experiments often ended in failure due to rejection caused by different genes or the risk of infection caused by viruses. In 2001, Swiss pharmaceutical company Novartis AG stopped its $1 billion xenotransplantation experiment for fear that the virus in the pig would be transmitted to humans. George Church, a professor of genetics at Harvard Medical School, solved the problem two years ago. He used a new gene editing tool called CRISPR that removes harmful viral genes. Since then, the company has established a company called eGenesis Bio, which specializes in breeding pigs that do not cause rejection or infection. The company received $38 million (about 260 million yuan) in venture capital last month. Coach pointed out that this technology will eventually allow researchers to collect more than a dozen different organs and tissues from a pig. It is expected that the first case of transplantation using modified pig organs will be carried out in clinical trials at the end of this year, but only the disease Patients who cannot wait for human organs can participate in the experiment. Dental Machine,Dental Equipment,Dental Instruments,Portable Dental Unit ZHEJIANG FOMOS MEDICAL TECHNOLOGY CO.,LTD. , https://www.ifomos.com